New research links diabetes drugs semaglutide and tirzepatide to a higher risk of rare optic nerve damage, raising safety concerns for patients.
Vous n'êtes pas connecté
New research links diabetes drugs semaglutide and tirzepatide to a higher risk of rare optic nerve damage, raising safety concerns for patients.
New research links diabetes drugs semaglutide and tirzepatide to a higher risk of rare optic nerve damage, raising safety concerns for patients.
New research has raised fresh concerns about the safety of btwo popular diabetes drugs-semaglutide and tirzepatide-linking them to a rare but...
The anti-obesity drug tirzepatide, known as Mounjaro (for diabetes) and Zepbound (for obesity), has been found to reduce breast cancer growth linked...
An international panel of experts has released updated treatment guidelines in The BMJ. They recommended that two newer types of medications—SGLT-2...
An international panel of experts has released updated treatment guidelines in The BMJ. They recommended that two newer types of medications—SGLT-2...
By now, you have probably heard about the weight-loss benefits of glucagon-like peptide-1 drugs such as Ozempic (semaglutide) and Mounjaro...
By now, you have probably heard about the weight-loss benefits of glucagon-like peptide-1 drugs such as Ozempic (semaglutide) and Mounjaro...
A new study by the U.S. Food and Drug Administration (FDA), published in the Annals of Internal Medicine, has raised concerns about a rare but...
A new study by the U.S. Food and Drug Administration (FDA), published in the Annals of Internal Medicine, has raised concerns about a rare but...
Current weight-loss and diabetes medications, such as GLP-1 drugs, often fail to deliver lasting results and are plagued by unpleasant side effects....